Shield Therapeutics Appoints Richard Jones as Chief Financial Officer
Shield Therapeutics AG announced that it has appointed Richard Jones to the newly created role of Chief Financial Officer.
Richard has more than 12 years of corporate finance and broking experience and was most recently Director and Head of Healthcare at Brewin Dolphin Investment Banking. During this time he has developed a wealth of experience in advising healthcare companies on financing transactions, including public market transactions, mergers and acquisitions. From early 2007 to October 2009, Richard was Director and Head of Healthcare at Investec Investment Banking and has also previously held various management roles within industry having originally trained as a chartered accountant at PricewaterhouseCoopers. Richard has been working closely with Shield’s management team as a non-executive Director and member of the Company’s Board since early 2010, having previously been retained as an advisor to the management team since 2008.
Other news from the department people
